• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Does Spirited Paw Launch Change The Bull Case For Chewy (CHWY)?

    Simply Wall St·11/10/2026 22:28:57
    Listen to the news
    • Standard Process, Inc. has made its Spirited Paw whole food companion animal supplements for dogs and cats available on Chewy.com, broadening nationwide access through a platform many pet parents already use for everyday supplies.
    • The addition of Spirited Paw’s farm-to-formula, whole food-based products strengthens Chewy’s pet health assortment and underlines demand for nutrition-focused wellness options in online pet retail.
    • This development may influence how some investors view Chewy’s investment narrative, given the addition of Spirited Paw’s whole food supplements to its marketplace.

    Scan other pet health plays related to similar wellness trends as Chewy by reviewing our curated list of 19 high quality undiscovered gems that focus on strong fundamentals and potential expansion.

    Chewy Investment Narrative Recap

    To own Chewy, you need to believe the business can turn its large pet supply platform into a higher margin health and services ecosystem, as set out in the analyst consensus Narrative on Simply Wall St. The near term swing factor is how quickly Autoship, Chewy Health and Vet Care can compound earnings while consumer spending on pets remains mixed.

    The main risk is that softer demand for premium treats and toppers lingers, which could cap both net sales and margin progress. The Spirited Paw launch looks directionally helpful for Chewy’s consumables mix, but on its own it does not rewrite the key short term catalyst or the biggest risk.

    The most relevant backdrop for this Spirited Paw partnership is Chewy Health and Chewy Vet Care. Analysts in that consensus Narrative on Simply Wall St frame those health and services channels, including clinics and higher margin wellness products, as important for future earnings and for making Autoship customers more valuable over time.

    Spirited Paw slots into that context as another health focused offering that can sit alongside prescriptions, supplements and Vet Care. It may support the idea that Chewy can use its site traffic and logistics to carry more wellness brands, although the real test remains execution in clinics, Autoship retention and cost savings from AI and automation.

    Chewy's narrative projects US$15.8b revenue and US$577.9 million earnings by 2029. This assumes 6.5% yearly revenue growth and an earnings increase of about US$304.2 million from US$273.7 million.

    Discover how Chewy's fair value indicates a 25% potential upside to its current price, which could materialize faster than many investors expect.

    NYSE:CHWY 1-Year Stock Price Chart
    NYSE:CHWY 1-Year Stock Price Chart

    Exploring Other Perspectives

    Some of the most optimistic Chewy analysts lean hard on a faster ramp in Chewy Vet Care and Modern Animal, expecting revenue of about US$16.4b and earnings near US$682.5 million by 2029. You can read that as a bet that health focused moves like the Spirited Paw launch could eventually reshape those pre news assumptions.

    Explore 4 other Chewy fair value estimates, including one that suggests as much as 150% upside from the current price.

    Form Your Own Verdict

    Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.

    Looking For More Ideas Beyond Chewy?

    If the Chewy story has you thinking about what else might fit your watchlist, widen the search with a few focused stock collections that line up with different risk and return profiles.